Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy.
Yang T, Dong Z, Du R, Wang Y, Liu L, Xue Y, Zhang X, Liao Y, Gan J, Yu X, Huang Y, Yang CG.
Yang T, et al. Among authors: liao y.
J Med Chem. 2025 Jun 27. doi: 10.1021/acs.jmedchem.5c00566. Online ahead of print.
J Med Chem. 2025.
PMID: 40579742